Presenter

After obtaining his PhD in Chemical Crystallography in 1992 he continued his research career at the University of Calgary in the area of protein crystallography. During this time, he was exposed to his first super computer the Fujitsu VPX240, and realized the impact HPC could have on scientific discovery. In 1998 he was awarded an HHMI Medical Fellowship working under the supervision of Professors Don Wiley and Steve Harrison in the area of macromolecular and computational crystallography at Harvard University. In 2004 he joined the Novartis Institutes for Biomedical Research as the Global lead for Scientific Computing, specializing in the application of High Performance, Data Analytics and Cloud Computing to advance drug discovery. After 14 years in the role, he moved to the Markley Group as CTO and subsequently joined AWS in 2020 as Principal Business Development Lead for HPC in Healthcare and Life Science.